As of 2025-07-06, the Intrinsic Value of Cell MedX Corp (CMXC) is -2.46 USD. This CMXC valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.45 USD, the upside of Cell MedX Corp is -650.19%.
Based on its market price of 0.45 USD and our intrinsic valuation, Cell MedX Corp (CMXC) is overvalued by 650.19%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -2.46 - -2.46 | -2.46 | -650.19% |
| P/E | (1.99) - (2.91) | (2.48) | -653.9% |
| DDM - Stable | (1.62) - (25.24) | (13.43) | -3098.3% |
| DDM - Multi | (1.54) - (18.82) | (2.86) | -737.6% |
| Market Cap (mil) | 0.62 |
| Beta | -5.11 |
| Outstanding shares (mil) | 1.38 |
| Enterprise Value (mil) | 0.90 |
| Market risk premium | 4.60% |
| Cost of Equity | 6.41% |
| Cost of Debt | 5.00% |
| WACC | 5.47% |